American Board of Anesthesiology
MD, S.U.N.Y., Downstate Medical Center
Internship, Internal Medicine
Brookdale Hospital Medical Center
Montefiore Medical Center
Mount Sinai Hospital
Kahn RA, Panah M, Kiffel S, Weinberger J. Modulation of ischemic excitatory neurotransmitter and GABA release during global temporary cerebral ischemia by local nitric oxide synthase inhibition. Anesth Analg. 1997 May; 84(5): 1004-10.
Marin ML, Parsons RE, Hollier LH, Mitty HA, Ahn J, Parsons RE, Temudom T, D'Ayala M, Mclaughlin M, Depalo L, Kahn RA. Impact of transrenal aortic endograft placement on endovascular graft repair of abdominal aortic aneurysms. J Vasc Surg. 1998 Oct; 28(4): 638-46.
Kahn R, Marin ML, Hollier L, Parsons R, Griepp RB. Induction of ventricular fibrillation to facilitate endocascular stent graft of thorscic airtic aneurysms. Anesthesiology 1998 February; 88(2): 534-536.
Moskowitz DM, Kahn RA, Konstadt SN, Mitty H, Hollier LH, Marin ML. Intraoperative transesophageal echocardiography as an adjuvant to fluoroscopy during endovascular thoracic aortic repair. Eur J Vasc Endovasc Surg. 1999 Jan; 17(1): 22-7.
Kahn RA, Moskowitz DM, Manspeizer HE, Reich DL, Mcconville JC, Marin ML, Hollier LH. Endovascular aortic reconstruction is associated with greater hemodynamic stability compared with open aortic reconstruction. J Cardiothorac Vasc Anesth. 1999 Feb; 13(1): 42-6.
Reich DL, Uysal S, Sliwinski M, Ergin MA, Kahn RA, Konstadt SN, Mccullough J, Hibbard M, Gordon WA, Griepp R. Neuropsychological outcome following deep hypothermic circulatory arrest in adults. J Thorac Cardiovasc Surg 1999; 117: 156-63.
Kahn RA, Moskowitz DM, Marin ML, Hollier LH, Parsons R, Teodorescu V, Mclaughlin M. Safety and efficacy of high dose adenosine to induce temporary asystole during endovascular abdominal aortic aneurysm repair. J Endovasc Ther 2000 Aug; 7(4): 292-6.
Temudom T, D'Ayala M, Marin ML, Hollier LH, Parsons R, Teodorescu V, Mitty H, Ahn J, Falk A, Kahn RA, Griepp R. Endovascular grafts in the treatment of thoracic aortic aneurysms and pseudoaneurysms. Ann Vasc Surg. 2000 May; 14(3): 230-8.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Kahn has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.